Dyadic International, Inc.(DYAI)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

DYAI Dyadic International, Inc.

交易中 08-17 10:11:32 EDT

0.7613

-0.0138

-1.78%

最高0.7700	最低0.7460	成交量23.73万
今开0.7460	昨收0.7751	日振幅3.10%
总市值3,050万	流通市值2,348万	总股本4,006万
成交额17.80万	换手率0.77%	流通股本3,084万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"DYAI","market":"US","secType":"STK","nameCN":"Dyadic International, Inc.","latestPrice":0.7613,"timestamp":1786975802468,"preClose":0.7751,"halted":0,"volume":237300,"delay":0,"changeRate":-0.01780415430267067,"floatShares":30839553,"shares":40063700,"eps":-0.212883,"marketStatus":"交易中","change":-0.0138,"latestTime":"08-17 10:11:32 EDT","open":0.746,"high":0.77,"low":0.746,"amount":178047.87483000002,"amplitude":0.030964,"askPrice":0.7852,"askSize":200,"bidPrice":0.7521,"bidSize":499,"shortable":3,"etf":0,"ttmEps":-0.212883,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1786996800000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":0.7751,"preHourTrading":{"tag":"盘前","latestPrice":0.7775,"preClose":0.7751,"latestTime":"09:15 EDT","volume":90557,"amount":70944.8078947,"timestamp":1786972530603,"change":0.0024,"changeRate":0.003096,"amplitude":0.451555},"postHourTrading":{"tag":"盘后","latestPrice":0.788,"preClose":0.7751,"latestTime":"19:57 EDT","volume":120,"amount":94.8714,"timestamp":1786751878486,"change":0.0129,"changeRate":0.016643,"amplitude":0.016643},"volumeRatio":8.873145,"impliedVol":1.59,"impliedVolPercentile":0.251},"requestUrl":"/m/hq/s/DYAI/tweets","defaultTab":"tweets","newsList":[{"id":"1183558984","title":"Dyadic International, Inc. 通过注册直接发行与同步私募配售成功融资290万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1183558984","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1183558984?lang=zh_cn&edition=full","pubTime":"2026-08-13 20:01","pubTimestamp":1786622470,"startTime":"0","endTime":"0","summary":"Dyadic International, Inc. 成功完成融资，总额达290万美元。这一资金是通过注册直接发行与同步私募配售两种方式共同实现的。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DYAI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1153169815","title":"Dyadic International 获新协议资格，可收取开发、商业及许可收入","url":"https://stock-news.laohu8.com/highlight/detail?id=1153169815","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1153169815?lang=zh_cn&edition=full","pubTime":"2026-08-04 19:28","pubTimestamp":1785842888,"startTime":"0","endTime":"0","summary":"根据新签署的协议，Dyadic International, Inc. 现已具备条件，能够收取开发款项、商业支付以及许可收入。这一进展标志着该公司在商业化路径上迈出了关键一步。协议的达成，为公司开辟了多元化的收入来源，不仅涵盖研发阶段的资金支持，还延伸至后续产品上市后的商业分成与知识产权授权收益。市场分析人士认为，此类结构化协议有助于降低研发风险，同时提升长期盈利预期。Dyadic International 作为一家专注于生物技术创新的企业，其技术平台的价值正通过此类合作得以兑现。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","DYAI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1109795602","title":"Dyadic International与欧洲生物科技公司达成新协议，扩展非动物乳制品管线","url":"https://stock-news.laohu8.com/highlight/detail?id=1109795602","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1109795602?lang=zh_cn&edition=full","pubTime":"2026-08-04 19:27","pubTimestamp":1785842829,"startTime":"0","endTime":"0","summary":"Dyadic International（DYAI）——通过一项与欧洲生物技术企业签署的最新协议，进一步扩大了其非动物乳制品管线。这一战略合作标志着公司在替代蛋白领域迈出重要一步。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DYAI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1101572690","title":"Dyadic International 突破性进展：15天内开发C1细胞系并生产本迪布焦埃博拉病毒抗原","url":"https://stock-news.laohu8.com/highlight/detail?id=1101572690","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1101572690?lang=zh_cn&edition=full","pubTime":"2026-07-28 20:32","pubTimestamp":1785241940,"startTime":"0","endTime":"0","summary":"Dyadic International, Inc. 近日宣布了一项令人瞩目的技术突破。该公司成功在短短15天内，开发出C1细胞系，并高效生产出本迪布焦埃博拉病毒抗原。这一进展，不仅展示了其平台技术的卓越能力，更预示着在应对新兴病毒威胁时，可能拥有更快速的响应路径。从细胞系的构建到抗原的规模化制造，整个流程被压缩至两周以内，这无疑为疫苗和治疗方法的研发，奠定了坚实且高效的基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DYAI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1193145467","title":"Dyadic International向FBS与Scripps交付C1平台生产的Bundibugyo埃博拉病毒抗原，用于临床前评估","url":"https://stock-news.laohu8.com/highlight/detail?id=1193145467","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1193145467?lang=zh_cn&edition=full","pubTime":"2026-07-28 20:32","pubTimestamp":1785241931,"startTime":"0","endTime":"0","summary":"Dyadic International（股票代码：DYAI）宣布，已向FBS与Scripps研究机构成功交付由C1蛋白表达平台生产的Bundibugyo埃博拉病毒抗原。这批抗原将用于临床前评估阶段，旨在探索针对该病毒的潜在疫苗或治疗策略。此举标志着公司在利用创新C1技术推动抗病毒研发方面迈出关键一步。该交付成果有望为后续的免疫原性研究与动物模型试验奠定基础，进一步验证C1平台在应对高致病性病原体中的适用性。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DYAI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1169409101","title":"Dyadic International拓展生物工业管线 新增专有工业酶项目","url":"https://stock-news.laohu8.com/highlight/detail?id=1169409101","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1169409101?lang=zh_cn&edition=full","pubTime":"2026-07-16 20:07","pubTimestamp":1784203629,"startTime":"0","endTime":"0","summary":"Dyadic International正在拓展其生物工业管线，新增了一项专有的工业酶项目。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","DYAI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1137653599","title":"Dyadic International 计划通过销售、合作、生产及授权推进商业化进程","url":"https://stock-news.laohu8.com/highlight/detail?id=1137653599","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1137653599?lang=zh_cn&edition=full","pubTime":"2026-07-16 20:02","pubTimestamp":1784203377,"startTime":"0","endTime":"0","summary":"Dyadic International 正积极采取多元化策略，旨在通过产品销售、战略合作、生产制造以及技术授权等多种途径，加速其技术的商业化进程。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","DYAI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1187432946","title":"Dyadic International与Scripps研究所将寻求合作伙伴与非稀释性资金以推动抗体与疫苗研发","url":"https://stock-news.laohu8.com/highlight/detail?id=1187432946","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1187432946?lang=zh_cn&edition=full","pubTime":"2026-05-28 19:27","pubTimestamp":1779967633,"startTime":"0","endTime":"0","summary":"Dyadic International, Inc.与Scripps研究所宣布，将共同寻求战略合作伙伴关系及非稀释性融资渠道，旨在加速其抗体与疫苗开发项目的进展。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","DYAI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1150145722","title":"Dyadic与Scripps研究所携手 加速汉坦病毒抗体与疫苗研发响应","url":"https://stock-news.laohu8.com/highlight/detail?id=1150145722","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1150145722?lang=zh_cn&edition=full","pubTime":"2026-05-28 19:26","pubTimestamp":1779967577,"startTime":"0","endTime":"0","summary":"生物技术公司Dyadic International, Inc. 与斯克里普斯研究所宣布建立合作关系，共同致力于开发针对汉坦病毒的快速响应抗体与疫苗。此项合作旨在结合双方在蛋白质表达平台与前沿免疫学研究方面的专长，以应对这一潜在致命病毒的公共卫生挑战。此次协作将利用Dyadic的创新型C1蛋白表达系统，旨在加速治疗性抗体与候选疫苗抗原的研发与生产进程。双方期望通过这一联合努力，为未来可能出现的汉坦病毒疫情构建更迅捷的医疗对策。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DYAI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518202286","title":"Dyadic International, Inc.盘中异动 股价大跌5.51%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518202286","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518202286?lang=zh_cn&edition=full","pubTime":"2025-03-11 03:02","pubTimestamp":1741633366,"startTime":"0","endTime":"0","summary":"北京时间2025年03月11日03时02分，Dyadic International, Inc.股票出现波动，股价急速下跌5.51%。Dyadic International, Inc.股票所在的生物技术行业中，整体涨幅为0.41%。其相关个股中，Mineralys Therapeutics, Inc.、Checkpoint Therapeutics, Inc.、Aeon Biopharma, Inc.涨幅较大，Aeon Biopharma, Inc.、Biodexa Pharmaceuticals Plc、Scisparc Ltd.较为活跃，换手率分别为6186.04%、3855.39%、1016.35%，振幅较大的相关个股有Aeon Biopharma, Inc.、Protagenic Therapeutics Inc C/Wts 29/04/2026 、Biodexa Pharmaceuticals Plc，振幅分别为90.44%、88.14%、59.34%。Dyadic International, Inc.公司简介：Dyadic International Inc是一家全球性的生物技术平台公司。这项技术基于戴亚迪国际公司命名为C1的Thermothelomyces heterothallica真菌。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031103024698a2dc66&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031103024698a2dc66&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["DYAI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517161808","title":"Dyadic International, Inc.盘中异动 股价大跌5.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517161808","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517161808?lang=zh_cn&edition=full","pubTime":"2025-03-06 22:32","pubTimestamp":1741271527,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日22时32分，Dyadic International, Inc.股票出现异动，股价大幅下挫5.52%。Dyadic International, Inc.股票所在的生物技术行业中，整体跌幅为0.66%。其相关个股中，Plus Therapeutics, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Exicure, Inc.涨幅较大，Plus Therapeutics, Inc.、Aeon Biopharma, Inc.、Allarity Therapeutics, Inc.较为活跃，换手率分别为953.51%、104.36%、48.88%，振幅较大的相关个股有Plus Therapeutics, Inc.、Entero Therapeutics Inc.、Astria Therapeutics, Inc.，振幅分别为24.20%、13.05%、11.88%。Dyadic International, Inc.公司简介：Dyadic International Inc是一家全球性的生物技术平台公司。这项技术基于戴亚迪国际公司命名为C1的Thermothelomyces heterothallica真菌。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306223208a2628fdd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306223208a2628fdd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["DYAI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516470670","title":"Dyadic International, Inc.盘中异动 早盘股价大涨8.57%报1.52美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516470670","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516470670?lang=zh_cn&edition=full","pubTime":"2025-03-04 22:50","pubTimestamp":1741099856,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日22时50分，Dyadic International, Inc.股票出现异动，股价快速拉升8.57%。截至发稿，该股报1.52美元/股，成交量5645股，换手率0.02%，振幅6.43%。Dyadic International, Inc.股票所在的生物技术行业中，整体涨幅为0.36%。Dyadic International, Inc.公司简介：Dyadic International Inc是一家全球性的生物技术平台公司。这项技术基于戴亚迪国际公司命名为C1的Thermothelomyces heterothallica真菌。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304225056989bb218&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304225056989bb218&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["DYAI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514385817","title":"Dyadic International, Inc.盘中异动 股价大涨6.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514385817","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514385817?lang=zh_cn&edition=full","pubTime":"2025-02-27 22:33","pubTimestamp":1740666803,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日22时33分，Dyadic International, Inc.股票出现波动，股价大幅拉升6.67%。Dyadic International, Inc.股票所在的生物技术行业中，整体涨幅为0.45%。其相关个股中，Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Alector, Inc.、Pasithea Therapeutics Corp C/Wts 12/08/2026 涨幅较大，Quoin Pharmaceuticals Ltd、Moleculin Biotech, Inc.、Aeon Biopharma, Inc.较为活跃，换手率分别为424.11%、92.29%、63.18%，振幅较大的相关个股有Quoin Pharmaceuticals Ltd、Neurosense Therapeutics Ltd C/Wts 10/11/2026 、天演药业，振幅分别为15.14%、14.83%、13.13%。Dyadic International, Inc.公司简介：Dyadic International Inc是一家全球性的生物技术平台公司。这项技术基于戴亚迪国际公司命名为C1的Thermothelomyces heterothallica真菌。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227223323a2567a87&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227223323a2567a87&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["DYAI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514864163","title":"Dyadic International, Inc.盘中异动 大幅跳水5.59%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514864163","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514864163?lang=zh_cn&edition=full","pubTime":"2025-02-27 03:54","pubTimestamp":1740599686,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日03时54分，Dyadic International, Inc.股票出现异动，股价大幅下挫5.59%。Dyadic International, Inc.股票所在的生物技术行业中，整体跌幅为0.53%。其相关个股中，Enveric Biosciences, Inc.、Renovaro Inc.、Apollomics Inc C/Wts 01/04/2028 涨幅较大，Enveric Biosciences, Inc.、Aeon Biopharma, Inc.、Organovo Holdings, Inc.较为活跃，换手率分别为6735.53%、311.73%、261.10%，振幅较大的相关个股有Enveric Biosciences, Inc.、Renovaro Inc.、Estrella Immunopharma Inc C/Wts 29/09/2028，振幅分别为194.07%、81.11%、61.50%。Dyadic International, Inc.公司简介：Dyadic International Inc是一家全球性的生物技术平台公司。这项技术基于戴亚迪国际公司命名为C1的Thermothelomyces heterothallica真菌。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227035447a2553ea9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227035447a2553ea9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["DYAI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514016388","title":"Dyadic International, Inc.盘中异动 急速上涨5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514016388","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514016388?lang=zh_cn&edition=full","pubTime":"2025-02-25 23:29","pubTimestamp":1740497365,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日23时29分，Dyadic International, Inc.股票出现波动，股价快速上涨5.07%。Dyadic International, Inc.股票所在的生物技术行业中，整体涨幅为0.80%。其相关个股中，Organovo Holdings, Inc.、Silexion Therapeutics Corp、Abpro Holdings Inc C/Wts 12/11/2029 涨幅较大，Gt Biopharma, Inc.、Organovo Holdings, Inc.、Moleculin Biotech, Inc.较为活跃，换手率分别为1066.07%、940.69%、593.09%，振幅较大的相关个股有Organovo Holdings, Inc.、Adial Pharmaceuticals, Inc、Silexion Therapeutics Corp，振幅分别为121.95%、64.05%、61.16%。Dyadic International, Inc.公司简介：Dyadic International Inc是一家全球性的生物技术平台公司。这项技术基于戴亚迪国际公司命名为C1的Thermothelomyces heterothallica真菌。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225232926a25394ec&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225232926a25394ec&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","DYAI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513172080","title":"Dyadic International, Inc.盘中异动 快速拉升6.80%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513172080","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2513172080?lang=zh_cn&edition=full","pubTime":"2025-02-24 22:56","pubTimestamp":1740408999,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日22时56分，Dyadic International, Inc.股票出现异动，股价急速上涨6.80%。Dyadic International, Inc.股票所在的生物技术行业中，整体涨幅为0.23%。其相关个股中，Pepgen Inc.、Estrella Immunopharma Inc C/Wts 29/09/2028、Telix Pharmaceutic涨幅较大，Pepgen Inc.、Aditxt, Inc.、Biodexa Pharmaceuticals Plc较为活跃，换手率分别为142.50%、59.62%、25.08%，振幅较大的相关个股有Pepgen Inc.、Telix Pharmaceutic、Aspire Biopharma Holdings Inc C/Wts 14/02/2030 ，振幅分别为137.23%、55.69%、41.14%。Dyadic International, Inc.公司简介：Dyadic International Inc是一家全球性的生物技术平台公司。这项技术基于戴亚迪国际公司命名为C1的Thermothelomyces heterothallica真菌。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502242256409890fc03&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502242256409890fc03&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["DYAI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512484274","title":"Dyadic International, Inc.盘中异动 临近午盘急速下跌7.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512484274","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512484274?lang=zh_cn&edition=full","pubTime":"2025-02-20 00:32","pubTimestamp":1739982778,"startTime":"0","endTime":"0","summary":"北京时间2025年02月20日00时32分，Dyadic International, Inc.股票出现异动，股价大幅下挫7.24%。Dyadic International, Inc.股票所在的生物技术行业中，整体涨幅为0.47%。其相关个股中，Osr Holdings, Inc.、Osr Holdings Inc C/Wts 02/09/2028 、Neurosense Therapeutics Ltd C/Wts 10/11/2026 涨幅较大，Aditxt, Inc.、Alzamend Neuro, Inc.、Osr Holdings, Inc.较为活跃，换手率分别为588.17%、244.73%、197.89%，振幅较大的相关个股有Osr Holdings Inc C/Wts 02/09/2028 、Osr Holdings, Inc.、Aditxt, Inc.，振幅分别为207.68%、159.49%、48.18%。Dyadic International, Inc.公司简介：Dyadic International Inc是一家全球性的生物技术平台公司。这项技术基于戴亚迪国际公司命名为C1的Thermothelomyces heterothallica真菌。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250220003259abd51699&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250220003259abd51699&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["DYAI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512533162","title":"Dyadic International, Inc.盘中异动 大幅下跌7.69%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512533162","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512533162?lang=zh_cn&edition=full","pubTime":"2025-02-19 00:20","pubTimestamp":1739895657,"startTime":"0","endTime":"0","summary":"北京时间2025年02月19日00时20分，Dyadic International, Inc.股票出现异动，股价急速下跌7.69%。Dyadic International, Inc.股票所在的生物技术行业中，整体涨幅为0.77%。其相关个股中，Estrella Immunopharma Inc C/Wts 29/09/2028、Allogene Therapeutics, Inc.、Solid Biosciences Inc.涨幅较大，Aditxt, Inc.、Moleculin Biotech, Inc.、Solid Biosciences Inc.较为活跃，换手率分别为389.85%、176.23%、148.25%，振幅较大的相关个股有Estrella Immunopharma Inc C/Wts 29/09/2028、Abvc Biopharma, Inc.、Allogene Therapeutics, Inc.，振幅分别为148.75%、92.00%、79.17%。Dyadic International, Inc.公司简介：Dyadic International Inc是一家全球性的生物技术平台公司。这项技术基于戴亚迪国际公司命名为C1的Thermothelomyces heterothallica真菌。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219002057abd3c6ad&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219002057abd3c6ad&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["DYAI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511469174","title":"Dyadic International, Inc.盘中异动 股价大跌5.27%报1.60美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511469174","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2511469174?lang=zh_cn&edition=full","pubTime":"2025-02-14 23:14","pubTimestamp":1739546042,"startTime":"0","endTime":"0","summary":"北京时间2025年02月14日23时14分，Dyadic International, Inc.股票出现波动，股价急速下挫5.27%。Dyadic International, Inc.股票所在的生物技术行业中，整体跌幅为0.02%。其相关个股中，Moleculin Biotech, Inc.、Cns Pharmaceuticals, Inc.、Abpro Holdings Inc C/Wts 12/11/2029 涨幅较大，Moleculin Biotech, Inc.、Cns Pharmaceuticals, Inc.、Virpax Pharmaceuticals, Inc.较为活跃，换手率分别为2318.74%、606.22%、466.63%，振幅较大的相关个股有Moleculin Biotech, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Cns Pharmaceuticals, Inc.，振幅分别为66.93%、43.67%、40.35%。Dyadic International, Inc.公司简介：Dyadic International Inc是一家全球性的生物技术平台公司。这项技术基于戴亚迪国际公司命名为C1的Thermothelomyces heterothallica真菌。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214231402a2460b02&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214231402a2460b02&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","DYAI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511529332","title":"Dyadic International, Inc.盘中异动 急速拉升5.56%报1.67美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511529332","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2511529332?lang=zh_cn&edition=full","pubTime":"2025-02-13 23:00","pubTimestamp":1739458831,"startTime":"0","endTime":"0","summary":"北京时间2025年02月13日23时00分，Dyadic International, Inc.股票出现异动，股价大幅拉升5.56%。Dyadic International, Inc.股票所在的生物技术行业中，整体涨幅为0.17%。其相关个股中，Edesa Biotech, Inc.、Enanta Pharmaceuticals, Inc.、Nutriband Inc C/Wts 涨幅较大，Edesa Biotech, Inc.、Tc Biopharm  Plc、Genprex, Inc.较为活跃，换手率分别为1590.76%、1101.43%、121.08%，振幅较大的相关个股有天演药业、Immatics N V C/Wts 01/07/2025 、Edesa Biotech, Inc.，振幅分别为103.88%、92.30%、73.65%。Dyadic International, Inc.公司简介：Dyadic International Inc是一家全球性的生物技术平台公司。这项技术基于戴亚迪国际公司命名为C1的Thermothelomyces heterothallica真菌。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250213230031a244b258&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250213230031a244b258&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["DYAI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.dyadic.com","stockEarnings":[{"period":"1week","weight":-0.2249},{"period":"1month","weight":-0.3647},{"period":"3month","weight":0.0735},{"period":"6month","weight":-0.0661},{"period":"1year","weight":-0.0311},{"period":"ytd","weight":-0.1754}],"compareEarnings":[{"period":"1week","weight":0.004},{"period":"1month","weight":0.0285},{"period":"3month","weight":0.0503},{"period":"6month","weight":0.1387},{"period":"1year","weight":0.2037},{"period":"ytd","weight":0.1385}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Dyadic International, Inc.于2002年9月在特拉华州注册成立。该公司是一家总部位于佛罗里达州朱庇特的全球生物技术公司，在美国开展业务，在荷兰设有卫星办事处。该公司开发、制造和商业化精密工程、无动物的重组蛋白和酶，用于生命科学、食品和营养以及生物工业市场。这些产品是使用Dyadic专有的微生物表达平台生产的，包括C1和Dapibus系统，这些平台能够以可扩展和成本效益高的方式生产用于研究、诊断、细胞培养、营养和工业生物技术的重组蛋白。公司利用第三方顾问、合同研究机构和制造合作伙伴来支持某些研究、开发和商业活动。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.002996},{"month":2,"riseRate":0.5,"avgChangeRate":0.016985},{"month":3,"riseRate":0.625,"avgChangeRate":0.046868},{"month":4,"riseRate":0.375,"avgChangeRate":-0.064089},{"month":5,"riseRate":0.666667,"avgChangeRate":0.10129},{"month":6,"riseRate":0.444444,"avgChangeRate":0.069298},{"month":7,"riseRate":0.444444,"avgChangeRate":0.004076},{"month":8,"riseRate":0.444444,"avgChangeRate":0.023776},{"month":9,"riseRate":0.5,"avgChangeRate":-0.035198},{"month":10,"riseRate":0.375,"avgChangeRate":-0.032718},{"month":11,"riseRate":0.375,"avgChangeRate":-0.005923},{"month":12,"riseRate":0.375,"avgChangeRate":-0.030251}],"exchange":"NASDAQ","name":"Dyadic International, Inc.","nameEN":"Dyadic International, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Dyadic International, Inc.(DYAI)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Dyadic International, Inc.(DYAI)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Dyadic International, Inc.,DYAI,Dyadic International, Inc.股票,Dyadic International, Inc.股票老虎,Dyadic International, Inc.股票老虎国际,Dyadic International, Inc.行情,Dyadic International, Inc.股票行情,Dyadic International, Inc.股价,Dyadic International, Inc.股市,Dyadic International, Inc.股票价格,Dyadic International, Inc.股票交易,Dyadic International, Inc.股票购买,Dyadic International, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Dyadic International, Inc.(DYAI)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Dyadic International, Inc.(DYAI)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}